Actualiteit

With the incorporation of genetic techniques, it has been possible to identify a greater number of microorganisms that cannot be analysed with a normal microbiological culture and that make up the vaginal microbiome. A powerful tool to identify the microbiome are the massive sequencing techniques. The analysis of the microbiome is important since, among other things, in the field of reproductive medicine it is possible to detect if there is a microorganism that can facilitate or hinder the implantation of the embryo.

Since one of the parameters that enable us to measure assisted reproductive treatment efficiency is embryo morphology, its research is highly critical.

A study performed in the molecular biology and genetics laboratory at Instituto Bernabeu, IB Biotech, and submitted to the Spanish Fertility Society (SEF) congress has concluded that there is an increased risk of embryo abnormalities in chromosomal segments in young women.

Research carried out by Instituto Bernabeu has concluded that the use of heparin, an anticoagulant drug, improves prognosis in courses of in vitro fertilisation treatment (IVF) and ICSI (intracytoplasmic sperm injection) in patients who have experienced recurrent pregnancy loss or repeated implantation failure.

Instituto Bernabeu has submitted research work managed by Belén Lledó, Director of the clinic's Genetics Unit, to the Spanish Fertility Society (SEF) congress. The research involved analysis of mitochondrial DNA (mtDNA) in embryos and its link to the success of in vitro fertilisation treatment (IVF).

Instituto Bernabeu has submitted research work to the 32^nd Spanish Fertility Society (SEF) National Congress held in Madrid. The aim of the study is to gain an understanding of drugs under conditions that differ from authorised use for courses of in vitro fertilisation (IVF) in patients with poor response, the frequency with which they are used in these cases and a review of the legal side to their administration. The research work is entitled: ‘Use of drugs under different conditions to those authorised within the framework of a course of in vitro fertilisation: a review of legal aspects and experience of use in patients with poor ovarian response.’

Parents' main aim in life is to ensure that their children are born healthy and that they, as parents, have the chance to ensure this happens. With this in mind, the Rafael Bernabeu Foundation makes its resources and research available so that people faced with health issues and also financial difficulties can try for children who are free of the illness they are carrying. The Rafael Bernabeu Foundation, Instituto Bernabeu's social wellness programme has, for many years, been offering preferential service when providing treatment for associations and social entities, including members of the Association in Support of the Mentally Ill of Alicante (Asociación Pro Discapacitados Psíquicos de Alicante, APSA). 

‘Patients with poor ovarian response have a different distribution in the follicle-stimulating hormone (FSHR) genotype.’ This is the title of the research work that Instituto Bernabeu gynaecologist, Yasmina Ben-Aicha, presented at the Spanish Fertility Society (SEF) congress. The leading national infertility event’s scientific committee has accepted a total of 16 pieces of Instituto Bernabeu research work, 12 of which are oral presentations given by their lead authors. 

The Instituto Bernabeu Group will once again attend the world's most significant reproductive medicine congress, both in terms of the work that is presented and in the number of specialists who attend.

Scientific research carried out by Instituto Bernabeu looked into the chances of a successful pregnancy using implanted embryos with chromosome mosaicism. It is a controversial issue because these embryos have a chromosomal abnormality in some cells and, until recently, these abnormalities were not detected. Thanks to current high-precision next-generation sequencing or NGS techniques and array-CGH during pre-implantation diagnosis for detecting aneuploidies, chromosomal abnormalities can be detected with precision in chromosome segments as well as in complete chromosomes.

Once again this year, Instituto Bernabeu was present at the 6^th edition of the Mediterranean Forum, a national gathering organised by Merck under the title ‘Human Reproduction’ where gynaecologists learn about the latest in the field. The Director of the Reproduction and Genetics Guidance Unit at Instituto Bernabeu, Dr Andrea Bernabeu, was present at the event where exchanges on very latest in the field of reproductive medicine take place. Her presentation was on new forms of ovarian stimulation. The gynaecologist covered new approaches using personalised treatment, new protocols and new means of administering pharmaceutical drugs.

The group of clinic’s aim, as it travelled to France in order to hold an informative event, is to make Instituto Bernabeu known beyond our frontiers and open up new horizons to foreign patients who are unable to get pregnant naturally.

The Rafael Bernabeu Foundation has launched the fifth edition of its €45,000 university student scholarship programme.

The 32^nd edition of the Spanish Fertility Society (SEF) National Congress held in Madrid has handed the Instituto Bernabeu Group an award for its work entitled ‘Engagement of nursing staff in assisted reproduction treatment: what is patient opinion?’ under the communication promoted to presentation category. The award was given by the Scientific and Organisation Committee of the 7^th edition of the National Nursing Congress that is held at the same time as SEF. The study in question was one of the 16 pieces of scientific research that Instituto Bernabeu presented at the leading national infertility congress. The clinic attends the congress every year and contributes work from its numerous fields of research.

The Medical Director at Instituto Bernabeu, Dr Rafael Bernabeu, recently participated in the Progress in Reproductive Medicine: Focus 2018 congress held in Italy. The event was held in Palermo, the Italian capital of science and life 2018, and it brought together leading international specialists in the field of reproductive medicine. His presentation was entitled ‘The potential of implanting mosaic embryos’ and it covered the next generation sequencing technique, the precision of which facilitates detection of embryos with mosaicism (they have cells with chromosomal abnormalities) and analysis of the chances that they have of implanting.

The medical codirector of Instituto Bernabeu, doctor Llácer, has participated in a masterclass in Greece attended by gynaecology professionals from across Europe. The expert on low ovarian reserve and director of the specific unit at Instituto Bernabeu spoke to his colleagues about the new personalized strategies for ovarian stimulation and subsequent handling in the obtaining of oocytes.

Rafael Bernabeu Charitable Foundation of Instituto Bernabeu, has celebrated the awards ceremony of the VIII Children's Drawing Contest on Motherhood. The reproductive medicine clinic Charitable Foundation, has presented the winners of the two categories, from 5 to 8 years and from 9 to 12 years with a diploma and a gift voucher of 300 euros, and with a diploma and a gift certificate of 100 euros to the two second places. The awards ceremony was held in the Sala Fnac Boulevard in Alicante and also another 16 children have received a diploma and a special gift.

As a part of our continuous training programme, an intensive theoretical and practical seminar entitled ‘Advanced Workshop in Embryo Biopsy: Techniques and tips for usage’ will take place next June. The workshop is aimed at reproduction biologists who are specialised in micro-handling techniques.

Instituto Bernabeu gynaecologist, Andrea Bernabeu, participated in the closing ceremony of the 3^rd edition of the Community Pharmacy Management and Optimisation of Pharmaceutical Care Master's Degree at the Miguel Hernández University (UMH) in Elche, a course on which she has participated as a lecturer. The closing ceremony of the third edition and official inauguration of the fourth edition was held in the ADDA auditorium in Alicante. It coincided with the 8^th edition of the National Congress of Community Pharmacists organised by SEFAC, the Spanish Society of Family and Community Pharmacies.

Instituto Bernabeu was present at the Italian Fertility, Sterility and Reproductive Medicine Society (SIFES) congress held in Riccione in Italy between 17^th and 19^th May. Paolo Cirillo, an Instituto Bernabeu gynaecologist, participated by giving two presentations at the gathering where experts in the field of infertility medicine meet. 

Instituto Bernabeu took a total of 16 pieces of research work to the 32^nd edition of the Spanish Fertility Society (SEF) National Congress. This is a significant quantity of work and, at the group of reproductive medicine clinics, research is an intrinsic part of its activity that is also put into practice during day-to-day provision of healthcare.

Eleven of the lines of research were presented as oral communications over the course of the event held between 16^th and 18^th May in Madrid’s convention centre where experts in reproductive medicine met.

The international congress entitled ‘A new approach to nursing in fertility’ held in the Instituto Bernabeu auditorium on 11^th and 12^th May brought together experts in infertility nursing from thirteen different countries. During the gathering, Dr Rafael Bernabeu, Medical Director at Instituto Bernabeu, highlighted the important role of nursing in reproductive medicine, a field in which Spain is a worldwide leader.

On 11^th and 12^th May, Instituto Bernabeu Alicante will organise a gathering of sixty experts in reproductive medicine nursing and auxiliary personnel with specialist skills in infertility. The most recent trends in this field will be covered in an international congress organised by Instituto Bernabeu and held in its headquarters in Alicante.

Juan Carlos Castillo, gynaecologist at the Instituto Bernabeu, has participated in a webinar (a talk given via internet in real time) offered by the English egg donation platform EggdonationFriends.com. The aim was to inform and respond to doubts sent by people around the world about infertility. 

Dr Joaquín Llácer, Medical Co-Director of Instituto Bernabeu, gave a speech at a conference held in Poland on treating patients with poor ovarian response and personalising courses of treatment.

‘IB International Workshop 2018: A new approach to nursing in fertility’ is the international congress due to be held on 11^th and 12^th May in the Instituto Bernabeu auditorium, Alicante. The event will bring together professionals from the field of nursing and experts in caring for reproductive medicine patients and, in doing so, share and explore knowledge that improves global care for these patients.

Instituto Bernabeu has been awarded the Whereivf.com international platform annual IVF PGD/PGS prize. Whereivf.com is the largest international directory of assisted reproduction clinics and the prize is awarded to clinics that stand out in complexity, innovation and efficiency to the benefit of its patients.

Under the headline ‘They are science’, the specialist healthcare magazine, Diario Sanitario, has selected Dr María Antonia López Rubio, a gynaecologist at Instituto Bernabeu in Albacete, Spain, to form part of an article on the role of women in the field of science. The publication highlights the work of female researchers in the Castilla La Mancha autonomous community. It presents the Instituto Bernabeu gynaecologist and cum laude Doctor of Medicine from the Autonomous University of Madrid as an example of hard work and perseverance. The aim of the publication is to shed light on the role of women in science. At Instituto Bernabeu, 80% of the team is female and over half over the management positions are the responsibility of female employees.

Children between 5 and 12 years of age can participate in one of two categories - one for children aged 5 to 8 years and another for children aged 9 to 12 years.

Instituto Bernabeu has embarked on a collaboration agreement with the Faculty of Medicine at the Complutense University of Madrid (UCM) so that students from one of the university’s courses can do work experience at the clinic located in Calle Ayala 48, Madrid.

The new Instituto Bernabeu Group newsletter is now available. Instituto Bernabeu has opened an elite reproductive medicine clinic in the heart of the Salamanca neighbourhood in Madrid's city centre.

The Instituto Bernabeu clinic will participate in a refresher course on reproductive medicine further to invitation by the Vall d’Hebrón Hospital which is organising an event for experts in the field in order to cover latest progress in obstetrics and reproduction.

Doctor Pino Navarro, an endocrinologist at the Instituto Bernabeu, has received institutional recognition from the Regional Government of Valencia for her research centred on women entitled “Diagnostic criteria of gestational diabetes. An update?”.

We have launched a new issue of Instituto Bernabeu corporate newsletter "IB Newsletter". Rafael Bernabeu Charitable Foundation opens the Fifth call for its scholarships for university students endowed with 45.000 euros. Students of Medicine, Nursing, Biology and Biotechnology of Universities from all over the country, that have brilliant trajectories and whose family income is an obstacle to continue their studies.

The Rafael Bernabeu Foundation has launched the fifth edition of its €45,000 university student scholarship programme.

Genetics tests carried out prior to conception mean that children can now be born free of certain illnesses. Molecular biology experts in the Instituto Bernabeu Genetics Department at IB Biotech will enable couples to have children who are free of health conditions thanks to the most groundbreaking techniques using the very latest technology. 

Instituto Bernabeu research presented at the 9^th edition of the Congress of the Society for the Study of Reproduction Biology (ASEBIR) held in Madrid found that the natural antioxidant cinnamtannin B1 present mainly in bay leaves and cinnamon protects spermatozoa from DNA damage. This natural protector increases the ability to fertilise the ovum and improves the quality of the embryos that are generated.

At the Association for the Study of Reproduction Biology (ASEBIR)'s 9th Congress held in Madrid, Instituto Bernabeu introduced a research paper focusing on checking the MLPA (Multiplex Ligation-dependent Probe Amplification) technique's sensitivity levels in order to find out how specific alterations can affect sperm production. Our investigation entitled: "New technique to detect Y chromosome microdeletion (YCM): Clinical implications” was based on the fact that Y chromosomes comprise different genetic regions involved with spermatogenesis or sperm production. In the event that one of these regions, also known as AZF, was deleted or duplicated, this could result in either a low amount or the complete absence of sperm.

The aim of the study led by Instituto Bernabeu gynaecologist, Francisco Sellers, and endorsed by the Association for the Study of Reproduction Biology (ASEBIR), was to determine if there are differences between the quantity of trophoblastic vascularisation during early stages of spontaneous pregnancies and pregnancies after assisted reproduction techniques (ART).

Instituto Bernabeu presented research work in poster format at the 9^th edition of the Congress of the Association for the Study of Reproduction Biology (Asebir) held in Madrid in November. The research is based on data obtained from observing if there is a relationship between the morphological characteristics of an embryo, in accordance with Asebir criteria, and the presence of mosaicism in blastocyst biopsies.

Instituto Bernabeu has presented research work entitled 'Is there a relationship between oocyte retrieval and maturation, and embryo aneuploidy and mosaicism rates?' at the 9^th edition of the Congress of the Association for the Study of Reproduction Biology (ASEBIR). The research focuses on the relationship between the number of oocytes retrieved and matured following ovarian puncture and rates of embryo aneuploidy and mosaicism (chromosomal and cellular abnormalities).

The new Instituto Bernabeu Group newsletter is now available. Andrea Bernabeu, PhD, MD, Gynaecologist at Instituto Bernabeu, has received in New York the Young Investigator Award for her work on advanced genetics techniques on chromosome alteration on embryos.  

Dr Belén Lledó, a molecular biologist at Instituto Bernabeu, has participated in an international gathering of experts in reproductive medicine genetic technologies held in Paris. The gathering included events covering the very latest in the field from both a technical and ethical point of view.

Instituto Bernabeu Group's commitment to the most demanding of quality levels has once again been reflected in a further annual renewal of the Quality Healthcare (QH) official certification for excellence in healthcare that is awarded by the Institute for Development and Integration of Healthcare (IDIS from the Spanish acronym).

Instituto Bernabeu has delivered research work on the detection of chromosomal mosaicism in embryos using next generation sequencing (NGS) and its influence on birth rates to the Association for the Study of Reproduction Biology (ASEBIR) congress to be held in Madrid. Thanks to this complex technique, the researchers have proven that low-grade mosaicism in the embryo does not affect the birth of healthy children to a significant degree.

Instituto Bernabeu is responsible for organising the 'IB International Workshop 2018: A new approach to nursing in fertility' international congress due to be held on 11^th and 12^th May 2018 in the auditorium at the clinic's headquarters in Alicante. The aim is to bring together professionals from the field of nursing and experts in caring for reproductive medicine patients and, in doing so, share and delve deep into knowledge that improves global care specifically for these patients.

On Friday 24^th November, Dr María Antonio López Rubio, a gynaecologist at Instituto Bernabeu in Albacete, will participate in the 22^st edition of the event organised by the Spanish Society of General Practitioners of Castilla La Mancha that is due to be held in Cuenca between 23^rd and 25^th November. 

Andrea Bernabeu, PhD, MD, Gynaecologist at Instituto Bernabeu, has received in New York the Young Investigator Award for her work on advanced genetics techniques on chromosome alteration on embryos. 

We have launched a new issue of Instituto Bernabeu corporate newsletter "IB Newsletter". Instituto Bernabeu deals with the most complex of cases because it has over 30 years' experience that are a guarantee of expert hands at a leading clinic where each case is given personalised treatment. Wasting time is not an option when we are racing against the clock. When the aim of that race is a pregnancy, it is impossible to recover missed opportunities. If a woman's age and the fact that she is not getting pregnant combine, there is only one possible piece of advice: Put yourself in the very best hands and do not leave what quality reproductive medicine can do for you to chance.

On 24^th November, the University of Alicante will hold the V Edition of Patent Rights and Biotechnology Event organised by Magister Lvcentinvs - the centre for Master's Degree education in Industrial and Intellectual Property at the University of Alicante.  At the event, university lecturers, lawyers and other experts in the field of biotechnology will cover specific aspects of the legal impact of scientific progress.

A team of researchers at Instituto Bernabeu has completed a prospective randomised clinical trial aimed at understanding if selection of an embryo generated during a cycle of in vitro fertilisation (IVF) is possible when morphological development is observed just once over the days leading up to transfer. The results of the research work will be presented at the national congress organised by the Association for the Study of Reproduction Biology due to be held in Madrid between 15^th and 17^th November.

Instituto Bernabeu will once again participate in the Association for the Study of Reproduction Biology (ASEBIR) Congress that is due to be held in Madrid between 15^th and 17^th November. The reproductive medicine clinic will present ten pieces of research work at the congress. Four of these were produced by the Embryology Unit at Instituto Bernabeu; another by the Egg Donation Unit; and the remaining pieces of work were carried out by the clinic's Molecular Biology and Genetics departments. 

The Medical Director of Instituto Bernabeu, Dr Rafael Bernabeu, will participate in the 5^th edition of the Contraception Congress organised by the Castilla La Mancha Contraception Society due to be held in Albacete on the 10^th and 11^th November. The Director of the Instituto Bernabeu Group, Dr Rafael Bernabeu, will cover the revolutionary discovery of the uses of anti-mullerian hormone in his speech entitled 'A new paradigm in contraception: AMH and derivatives.'

We have launched a new issue of Instituto Bernabeu corporate newsletter "IB Newsletter". Within the framework of annual support given to university studies, the Rafael Bernabeu Social Welfare Foundation at Instituto Bernabeu has awarded scholarships to six Medicine and Nursing university students. The scholarships have a value of 2,500 euros each.

Instituto Bernabeu will present a study entitled 'Embryo mosaicism and its impact on the results of cycles of in vitro fertilisation (IVF) and associated factors' at the 19^th edition of the Congress of the Association for the Study of Reproduction Biology (ASEBIR) due to be held in Madrid between 15^th and 17^th November.

The clinic has promoted a scientific exchange in which prominent specialists from the Region of Murcia participate in a conference that takes place at the Universidad Politécnica of Cartagena on Friday 1^st December.

Instituto Bernabeu will present one of its lines of research work in North America. It will do so at the American Society of Reproductive Medicine Congress (ASRM) due to be held between 28^th October and 1^st November in San Antonio and the research consists of a clinical trial for improving patient comfort during assisted reproduction treatment. 

A multidisciplinary team of professionals from Instituto Bernabeu, including Gynaecologists, Biologists, Geneticists, Pharmacists and Embryologists, participates as speakers at the opening of the IV Course on Stem Cells and Clinical Human Embryology, taking place on the 27^th October. This is a theoretical-practical course organized by the Biotechnology Department of the University of Alicante.

Within the framework of annual support given to university studies, the Rafael Bernabeu Social Welfare Foundation at Instituto Bernabeu has awarded scholarships to six Medicine and Nursing university students.

Pharmacy Faculty students are today, Thursday 27^th October, participating in an embryology workshop being held at Instituto Bernabeu in Alicante as part of the XIII edition of the Congress of Pharmacy Students organised by the Miguel Hernández University at its San Juan campus.

The Bar Association of Madrid requested the intervention of expert geneticists from Instituto Bernabeu in its event on paternity tests, a gathering of scientists and lawyers held on 23^rd October at the bar association's headquarters.

The Instituto Bernabeu is helping out once again this year in the University Master’s on Community Pharmacy Direction and Management & Optimization of Pharmaceutical Care organised by the Universidad Miguel Hernández (UMH). Doctor Andrea Bernabeu has taken part in this fourth edition that deals with aspects related to pregnancy and maternal-child health with theoretical and practical classes.

The Instituto Bernabeu and the Chair of Reproductive Medicine of Alicante University (UA) have presented a research project related to smoking and fertility at the 19^th Congress of the Spanish Society of Histology and Tissue Engineering, the 4^th Ibero-American Congress of Histology and the 7^th International Congress of Histology and Tissue Engineering held in Santiago de Compostela.

Advanced maternal age is the main factor associated with chromosome abnormalities or aneuploidies in the embryo, which cause problems during the pregnancy and increase the risk of miscarriage. 

Together with the Association of Pharmacists of Albacete, Instituto Bernabeu is organising the Pharmacotherapy in Reproductive Medicine course due to be held in the association's conference hall in Albacete. The four-day course will be held on 17^th October, 24^th October, 7^th November and 14^th November. 

At the 9^th edition of the Association for the Study of Reproduction Biology (ASEBIR) Congress to be held in Madrid between 15^th and 17^th November, Instituto Bernabeu will present the results obtained when evaluating a new means of administering drugs during ovarian stimulation that reduces the number of injections required. 

Sensitive to social causes for years, Instituto Bernabeu has been involved one more year in the awareness month of Breast Cancer. Under the title, "Feel that you love me" Instituto Bernabeu Foundation organizes a day, Tuesday 24th October, to address gynaecological cancer with patient’s testimonies and experts opinions.

Specialists from the Embryology Unit at Instituto Bernabeu will present research work entitled 'Conventional IVF improves the results of an egg donation programme compared with the use of ICSI' at the 9^th edition of the Association for the Study of Reproduction Biology (ASEBIR) Congress to be held in Madrid between 15^th and 17^th November. 

We have launched a new issue of Instituto Bernabeu corporate newsletter "IB Newsletter". In this occasion, to inform you about the Genetic Compatibility Test carried out at Instituto Bernabeu, that allows to detect more than 600 hereditary diseases that we can pass on to our future children.

The new Instituto Bernabeu Group newsletter is now available, dedicated to our last reserach work accepted at congress ESHRE 2017.

For the sixth year in a row, Instituto Bernabeu (IB) and the University of Alicante (UA), through the Reproductive Medicine Professorship, are organising a Master's Course in Reproductive Medicine. 

As a part of our continuous training programme, an intensive theoretical and practical seminar entitled ‘Advanced Workshop in Embryo Biopsy: Techniques and tips for usage’ will take place next September. The workshop is aimed at reproduction biologists who are specialised in micro-handling techniques.

The researchers look at the selection that can be made of chromosomally normal embryos with preimplantation genetic screening (PGS) by using the next-generation sequencing (NGS) technique. This leads to an improvement in the results of in-vitro fertilization (IVF) since it detects chromosomally normal embryos, those which are abnormal and also those known as mosaic, which have both normal and abnormal cells. In the case of mosaic embryos, studies show that the abnormal cells are replaced with normal cells and that they may be implanted and are able to develop into a healthy child, although the success rate is somewhat lower.

The Instituto Bernabeu presents a study on the prevention of DNA fragmentation of sperm, thanks to natural antioxidants, at the international meeting of specialists in reproductive medicine organized by the European Society of Human Reproduction and Embryology (ESHRE).

Researchers of the Instituto Bernabeu present a study at the meeting of the European Society of Human Reproduction and Embryology (ESHRE), held in Switzerland from 2 to 5 July, in which new techniques are applied to enable more precise detection of sperm production.

The research by the Instituto Bernabeu studies the influence of cytokines, molecules that mediate in immune response with consequences such as inflammation, and which would enable early detection of endometriosis.

Instituto Bernabeu in Albacete and Alicante (IB), in collaboration with the University of Castilla-La Mancha (UCLM) are organising the second edition of the Master's Course in Male Infertility. 

New issue of Instituto Bernabeu corporate newsletter (IB NEWSLETTER). Our fertility and gynaecology clinic in Benidorm is under renovation, with new facilities and cutting edge technology in order to maintain our high quality, personalised service.

A study by the Instituto Bernabeu has found a correlation between embryo quality and a greater probability of the appearance of mosaicism, the presence of normal cells together with other abnormal cells. For some time, the Instituto Bernabeu has followed different lines of research related to embryo mosaicism and its detection, since these embryos may have lower implantation rates and a greater risk of aneuploidy, a chromosomal abnormality that may lead to genetic disorders.

At Instituto Bernabeu, we are an innovative medical centre which applies the latest, cutting edge technologies and techniques to improve our patient's living standards.

Dr. Joaquin Llacer, associate director at Instituto Bernabeu, has been elected to represent all Spanish specialist doctors at the European Society of Human Reproduction and Embryology.

Everything is changing in order to ensure that all remains the same. That is, offering a personalised treatment to every patient attending Instituto Bernabeu.

A study by the Instituto Bernabeu selected by the committee of experts of the international meeting of the European Society of Human Reproduction and Embryology, held from 2 to 5 July in Geneva, finds a correlation between the manner in which embryo division takes place and the future chromosome count of the embryo. 

New issue of Instituto Bernabeu corporate newsletter (IB NEWSLETTER). Instituto Bernabeu leads the new research for the treatment of implantation failure of the embryo and its link with recurrent miscarriage. One of these lines of work is focused on the personalization of the treatment to the specific response of each patient.

Instituto Bernabeu has revolutionised the way in which drugs for ovarian stimulation are used. Three days' worth of medicine can be taken in a single injection thanks to a device known as the i-Port which is already being used by diabetics. During courses of fertility treatment and when ovarian stimulation lasting an average of ten days is carried out, drugs need to be administered using injections. Many of the women who come to our clinic admit to being afraid of needles.

The Instituto Bernabeu Group will travel to Switzerland where the reproductive medicine clinic will present eleven pieces of research work carried out by experts at the reproductive medicine clinic. The international scientific committee at the European Society of Human Reproduction and Embryology has selected the research that will be made public during the 33^rd edition of the annual congress to be held between 2^nd and 5^th July in Geneva.

Patients undergoing treatment in the egg donation programme and patients undergoing frozen embryo transfer need to be administered progesterone. It is necessary for implantation and for the posterior progress of the pregnancy. Drugs can be administered either by means of a daily subcutaneous injection or vaginally over a period of at least three months. Given that this is a significant period of time, Instituto Bernabeu believes that it is key that the female patient feels at ease if she is to have a good quality of life.

At the European Society of Human Reproduction and Embryology (ESHRE) congress, Instituto Bernabeu will present work on how genetics affects responses to drugs and how they can be used in order to improve ovarian stimulation in women with poor response. The reproductive medicine clinic has pioneered the use of drugs linked to genetics through IBgen and, on this occasion, has developed research work entitled 'A pharmacogenetic approach to improving low ovarian response with androgen pre-treatment'. It will be presented at the event to be held between 2^nd and 5^th July in Switzerland.

The Director of the Endocrinology and Nutrition Department at Instituto Bernabeu, Dr Pino Navarro, will participate as a speaker in the XXII edition of the Continuous Training Course on Endocrinology and Nutrition for internal resident doctors organised by the Spanish Endocrinology and Nutrition Society. Dr Navarro will give a practical workshop on endocrinology and fertility.

Instituto Bernabeu will present research work entitled 'Factors associated with chromosomal mosaicism in trophoectoderm cells' at the European Society of Human Reproduction and Embryology (ESHRE) congress to be held between 2^nd and 5^th July in Geneva, Switzerland.

For the seventh year in a row, the Instituto Bernabeu Social Welfare Foundation has awarded prizes to the winners of the VII edition of the Children's Drawing Competition in which children represent how they see and understand maternity. Out of over 300 entries, the jury selected 7-year-old Rubén Cano Mateo's 'For my super-Mum' picture in the 5 to 8 years of age category. Ester Tomás, aged 12, was the winner of the 9 to 12 years of age category with her picture entitled 'Soon there'll be one more in the family'.

The aim of the study, which has been published in the Iberoamerican Fertility Journal, is based on understanding the possible relationship between the quality of embryos transferred during in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI) cycles with the presence of abnormalities in the foetus.

The Rafael Bernabeu Charitable Foundation, has received 300 children's drawings related to maternity in the contest organized by the organization for the seventh consecutive year.

Instituto Bernabeu has published research work in the Iberoamerican Fertility Journal on the effects of assisted reproduction techniques on placental vascularisation. 

Systems Biology in Reproductive Medicine, the scientific journal that primarily addresses matters associated with reproductive biology, recently published research work carried out by Instituto Bernabeu on the implantation of mosaic embryos.  The research work, entitled Implantation potential of mosaic embryos, deals with the chances of achieving full term pregnancies when transferring certain mosaic embryos. 

Dr Rafael Bernabeu will participate in a seminar which is part of the Master's Course in Healthcare Management at Miguel Hernández University (Sant Joan d'Alacant campus). The lecture is entitled 'Innovation in private management. Challenges and Solutions.'

The Instituto Bernabeu Group social enterprise - the Rafael Bernabeu Social Welfare Foundation - has donated 2,000 euros to the Rafiki Africa Foundation in support of a number of humanitarian projects. 

Instituto Bernabeu is today celebrating World DNA Day with a visit of its facilities by 15 and 16-year-old students from Jaime II secondary school in Alicante. The clinic is opening its doors to the students so that they can get a close look at the work that takes place in a human genetics laboratory. 

Instituto Bernabeu research on 'Next-generation sequencing in order to detect low-level mosaicism and its effect on live birth rates' was one of the pieces of research work presented at the 16^th edition of the Pre-implantation Genetic Diagnosis Conference organised by the Pre-implantation Genetic Diagnosis International Society (PGDIS) held between 26^th and 29^th March in Valencia. The research was led by Dr Rafael Bernabeu and the Medical Co-Director, Joaquín Llácer, along with doctors Ruth Morales, Belén Lledó, José Antonio Ortiz, Jorge Ten and Eva García-Hernández.

The new Instituto Bernabeu Group newsletter is now available, dedicated to the international platform, Whereivf.com, has chosen to name us IVF Agency of the Year, 2016. 

The Medical Director of Instituto Bernabeu, Dr Rafael Bernabeu, has been named a referee of the scientific magazine, Human Reproduction, among other scientists. Dr Bernabeu will take the role of evaluator and reviewer of the scientific quality of research work reaching the publication which focuses on the field of human reproduction.

Instituto Bernabeu will present its research work entitled 'Factors associated with chromosomal mosaicism in trophoectoderm cells' at the 16^th edition of the International Conference on Pre-implantation Genetic Diagnosis organised by the Pre-implantation Genetic Diagnosis International Society. 

Instituto Bernabeu will present two pieces of research work at the 16^th edition of the International Conference on Pre-implantation Genetic Diagnosis organised by the Pre-implantation Genetic Diagnosis International Society (PGDIS) to be held between the 26^th and 29^th March in Valencia.

New issue of Instituto Bernabeu corporate newsletter (IB NEWSLETTER). The Rafael Bernabeu Foundation launches the VII edition of the children's maternity-related art competition.

Dr Rafael Bernabeu's professional and entrepreneurial background will serve as an example and as inspiration at the 2^nd edition of the 2017 Inspirational Business Awards organised by Jovempa and due to be held on 24^th March. 

Children between 5 and 12 years of age can participate in one of two categories - one for children aged 5 to 8 years and another for children aged 9 to 12 years.

The new Instituto Bernabeu Group newsletter is now available, dedicated to full house at the concert in honour of women.

The gathering of national experts is to be held at the Royal Academy of Medicine in Madrid on 9^th and 10^th March.

At the symposium, Instituto Bernabeu will present the new strategies it is developing in order to treat patients with poor ovarian response. The event, entitled Current Issues in Assisted Reproduction, is organised by the University of Alcalá, the Autonomous University of Madrid and Ginefiv.

For the fifth year in a row, the Rafael Bernabeu Foundation, Instituto Bernabeu's social welfare organisation, chose music as the means to honour women on International Women's Day on 8^th March. 

Instituto Bernabeu has received the 'IVF Agency of the Year 2016' IVF Clinics Awards given by the international on-line platform, Whereivf.com. The award recognises quality of care, results obtained and corporate communication. Its aim is to highlight institutions and organisms that stand out in terms of their exceptional outlook for patients.